(Q77701406)
Statements
Poor response rate to a continuous schedule of Amifostine therapy for 'low/intermediate risk' myelodysplastic patients (English)
D T Bowen
C Denzlinger
W Brugger
D Culligan
K Gelly
S Adlakha
M Groves
M Hepburn
1 December 1998